Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Characteristics of older adults using patient web portals to view their DXA results.

Edmonds S, Lou Y, Robinson B, Cram P, Roblin DW, Wright NC, Saag K, Wolinsky FD.

BMC Med Inform Decis Mak. 2019 Sep 18;19(1):187. doi: 10.1186/s12911-019-0904-y.

2.

Combating resistance while maintaining innovation: the future of antimicrobial stewardship.

Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH.

Future Microbiol. 2019 Sep 17. doi: 10.2217/fmb-2019-0227. [Epub ahead of print]

3.

Considerations for Identifying Social Needs in Health Care Systems: A Commentary on the Role of Predictive Models in Supporting a Comprehensive Social Needs Strategy.

Nau C, Adams JL, Roblin D, Schmittdiel J, Schroeder E, Steiner JF.

Med Care. 2019 Sep;57(9):661-666. doi: 10.1097/MLR.0000000000001173. No abstract available.

PMID:
31404012
4.

Noninfectious Foodborne Exposures Reported to 2 National Reporting Systems, United States, 2000-2010.

Law RKY, Kisselburgh H, Roblin D, Choudhary E, Schier J, Fraser M, Taylor E.

Public Health Rep. 2019 Sep/Oct;134(5):552-558. doi: 10.1177/0033354919862690. Epub 2019 Aug 6.

PMID:
31386820
5.

Using Syndromic Surveillance to Evaluate the Respiratory Effects of Fine Particulate Matter.

Fuller CH, Roblin D, Jones J.

Ann Am Thorac Soc. 2019 Jul;16(7):930-933. doi: 10.1513/AnnalsATS.201902-118RL. No abstract available.

PMID:
30840829
6.

Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.

Solimeo SL, Nguyen VT, Edmonds SW, Lou Y, Roblin DW, Saag KG, Cram P, Wolinsky FD.

Osteoporos Int. 2019 May;30(5):1033-1041. doi: 10.1007/s00198-019-04854-6. Epub 2019 Jan 30.

PMID:
30701343
7.

The prevalence of overtreatment of osteoporosis: results from the PAADRN trial.

Hall SF, Wright NC, Wolinsky FD, Lou Y, Edmonds S, Roblin D, Jones M, Saag K, Cram P.

Arch Osteoporos. 2018 Sep 28;13(1):103. doi: 10.1007/s11657-018-0517-6.

PMID:
30267162
8.

Agreement between medical records and self-reports: Implications for transgender health research.

Gerth J, Becerra-Culqui T, Bradlyn A, Getahun D, Hunkeler EM, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Tangpricha V, Vupputuri S, Goodman M.

Rev Endocr Metab Disord. 2018 Sep;19(3):263-269. doi: 10.1007/s11154-018-9461-4. Review.

9.

Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.

Getahun D, Nash R, Flanders WD, Baird TC, Becerra-Culqui TA, Cromwell L, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Silverberg MJ, Safer J, Slovis J, Tangpricha V, Goodman M.

Ann Intern Med. 2018 Aug 21;169(4):205-213. doi: 10.7326/M17-2785. Epub 2018 Jul 10.

10.

Encouraging Patients to Speak up About Problems in Cancer Care.

Mazor KM, Kamineni A, Roblin DW, Anau J, Robinson BE, Dunlap B, Firneno C, Gallagher TH.

J Patient Saf. 2018 Jun 27. doi: 10.1097/PTS.0000000000000510. [Epub ahead of print]

PMID:
29957680
11.

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.

Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, Stones R, Sinclair N, Hodgson K, Bowett SA, Roblin D, Traversa S, Plummer R, Veal G, Langtry JAA, Ashworth A, Burn J, Rajan N.

JAMA Dermatol. 2018 Aug 1;154(8):913-921. doi: 10.1001/jamadermatol.2018.1610.

12.
13.

Mental Health of Transgender and Gender Nonconforming Youth Compared With Their Peers.

Becerra-Culqui TA, Liu Y, Nash R, Cromwell L, Flanders WD, Getahun D, Giammattei SV, Hunkeler EM, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Sandberg DE, Silverberg MJ, Tangpricha V, Goodman M.

Pediatrics. 2018 May;141(5). pii: e20173845. doi: 10.1542/peds.2017-3845. Epub 2018 Apr 16.

14.

Nicotine addiction management following surgery: a quality improvement approach in the post anesthesia care unit.

Finegan BA, Roblin D, Hammal F.

Int J Qual Health Care. 2018 Jun 1;30(5):390-395. doi: 10.1093/intqhc/mzy036.

PMID:
29547920
15.

Association Between Gender Confirmation Treatments and Perceived Gender Congruence, Body Image Satisfaction, and Mental Health in a Cohort of Transgender Individuals.

Owen-Smith AA, Gerth J, Sineath RC, Barzilay J, Becerra-Culqui TA, Getahun D, Giammattei S, Hunkeler E, Lash TL, Millman A, Nash R, Quinn VP, Robinson B, Roblin D, Sanchez T, Silverberg MJ, Tangpricha V, Valentine C, Winter S, Woodyatt C, Song Y, Goodman M.

J Sex Med. 2018 Apr;15(4):591-600. doi: 10.1016/j.jsxm.2018.01.017. Epub 2018 Feb 17.

16.

Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) study.

Roblin DW, Cram P, Lou Y, Edmonds SW, Hall SF, Jones MP, Saag KG, Wright NC, Wolinsky FD; PAADRN Investigators.

Arch Osteoporos. 2018 Jan 6;13(1):4. doi: 10.1007/s11657-017-0402-8.

PMID:
29307094
17.

Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people.

Quinn VP, Nash R, Hunkeler E, Contreras R, Cromwell L, Becerra-Culqui TA, Getahun D, Giammattei S, Lash TL, Millman A, Robinson B, Roblin D, Silverberg MJ, Slovis J, Tangpricha V, Tolsma D, Valentine C, Ward K, Winter S, Goodman M.

BMJ Open. 2017 Dec 27;7(12):e018121. doi: 10.1136/bmjopen-2017-018121.

18.

Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis.

Alford SH, Divine G, Chao C, Habel LA, Janakiraman N, Wang Y, Feigelson HS, Scholes D, Roblin D, Epstein MM, Engel L, Havstad S, Wells K, Yood MU, Fortuny J, Johnson CC; Cancer Research Network Lymphoma Study Group.

Cancer Causes Control. 2018 Jan;29(1):143-156. doi: 10.1007/s10552-017-0987-7. Epub 2017 Nov 30.

19.

Perception of Community Tolerance and Prevalence of Depression among Transgender Persons.

Owen-Smith AA, Sineath C, Sanchez T, Dea R, Giammattei S, Gillespie T, Helms MF, Hunkeler EM, Quinn VP, Roblin D, Slovis J, Stephenson R, Sullivan PS, Tangpricha V, Woodyatt C, Goodman M.

J Gay Lesbian Ment Health. 2017;21(1):64-76. doi: 10.1080/19359705.2016.1228553. Epub 2016 Aug 26.

20.

Validity, reliability, and responsiveness to change of the "Osteoporosis and You" knowledge scale.

Nguyen VT, Edmonds SW, Lou Y, Roblin DW, Saag KG, Cram P, Wolinsky FD.

Osteoporos Int. 2017 Dec;28(12):3379-3388. doi: 10.1007/s00198-017-4204-z. Epub 2017 Sep 7.

21.

Cohort study of cancer risk among insured transgender people.

Silverberg MJ, Nash R, Becerra-Culqui TA, Cromwell L, Getahun D, Hunkeler E, Lash TL, Millman A, Quinn VP, Robinson B, Roblin D, Slovis J, Tangpricha V, Goodman M.

Ann Epidemiol. 2017 Aug;27(8):499-501. doi: 10.1016/j.annepidem.2017.07.007. Epub 2017 Jul 22. No abstract available.

PMID:
28780974
22.

Evaluation of a "Just-in-Time" Nurse Consultation on Bone Health: A Pilot Randomized Controlled Trial.

Roblin DW, Zelman D, Plummer S, Robinson BE, Lou Y, Edmonds SW, Wolinsky FD, Saag KG, Cram P.

Perm J. 2017;21:16-112. doi: 10.7812/TPP/16-112.

23.

The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.

Wolinsky FD, Hall SF, Lou Y, Edmonds SW, Saag KG, Roblin DW, Wright NC, Jones MP, Cram P; PAADRN Investigators, Curtis JR, Morgan SL, Schlechte JA, Williams JH, Zelman DJ.

Osteoporos Int. 2017 Oct;28(10):3061-3066. doi: 10.1007/s00198-017-4113-1. Epub 2017 Jun 15.

24.

Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy.

Hall SF, Edmonds SW, Lou Y, Cram P, Roblin DW, Saag KG, Wright NC, Jones MP, Wolinsky FD.

J Am Pharm Assoc (2003). 2017 Jul - Aug;57(4):503-509. doi: 10.1016/j.japh.2017.05.003. Epub 2017 Jun 8.

25.

The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.

Wolinsky FD, Lou Y, Edmonds SW, Saag KG, Roblin DW, Wright NC, Jones MP, Cram P; PAADRN Investigators.

Osteoporos Int. 2017 Oct;28(10):3055-3060. doi: 10.1007/s00198-017-4101-5. Epub 2017 Jun 1.

26.

Provider type and management of common visits in primary care.

Roblin DW, Liu H, Cromwell LF, Robbins M, Robinson BE, Auerbach D, Mehrotra A.

Am J Manag Care. 2017 Apr;23(4):225-231.

27.

Prevalence and causes of work disability among working-age U.S. adults, 2011-2013, NHIS.

Theis KA, Roblin DW, Helmick CG, Luo R.

Disabil Health J. 2018 Jan;11(1):108-115. doi: 10.1016/j.dhjo.2017.04.010. Epub 2017 Apr 25.

PMID:
28476583
28.

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study.

Vickers RJ, Tillotson GS, Nathan R, Hazan S, Pullman J, Lucasti C, Deck K, Yacyshyn B, Maliakkal B, Pesant Y, Tejura B, Roblin D, Gerding DN, Wilcox MH; CoDIFy study group.

Lancet Infect Dis. 2017 Jul;17(7):735-744. doi: 10.1016/S1473-3099(17)30235-9. Epub 2017 Apr 28.

29.

Statin use and risk of multiple myeloma: An analysis from the cancer research network.

Epstein MM, Divine G, Chao CR, Wells KE, Feigelson HS, Scholes D, Roblin D, Ulcickas Yood M, Engel LS, Taylor A, Fortuny J, Habel LA, Johnson CC.

Int J Cancer. 2017 Aug 1;141(3):480-487. doi: 10.1002/ijc.30745. Epub 2017 May 15.

30.

Racial Differences and Disparities in Osteoporosis-related Bone Health: Results From the PAADRN Randomized Controlled Trial.

Cram P, Saag KG, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Wolinsky FD; PAADRN Investigators*.

Med Care. 2017 Jun;55(6):561-568. doi: 10.1097/MLR.0000000000000718.

31.

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.

Cranston A, Stocken DD, Stamp E, Roblin D, Hamlin J, Langtry J, Plummer R, Ashworth A, Burn J, Rajan N.

Trials. 2017 Mar 7;18(1):111. doi: 10.1186/s13063-017-1812-z.

32.

Understanding Preferences for Osteoporosis Information to Develop an Osteoporosis Patient Education Brochure.

Edmonds SW, Solimeo SL, Nguyen VT, Wright NC, Roblin DW, Saag KG, Cram P.

Perm J. 2017;21:16-024. doi: 10.7812/TPP/16-024. Epub 2016 Nov 18.

33.

Determinants of and Barriers to Hormonal and Surgical Treatment Receipt Among Transgender People.

Sineath RC, Woodyatt C, Sanchez T, Giammattei S, Gillespie T, Hunkeler E, Owen-Smith A, Quinn VP, Roblin D, Stephenson R, Sullivan PS, Tangpricha V, Goodman M.

Transgend Health. 2016 Jul 1;1(1):129-136. eCollection 2016.

34.

Activating Patients With a Tailored Bone Density Test Results Letter and Educational Brochure: the PAADRN Randomized Controlled Trial.

Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Jones MP, Wright NC, Saag KG, Cram P, Roblin DW; PAADRN Investigators.

J Clin Densitom. 2017 Oct - Dec;20(4):464-471. doi: 10.1016/j.jocd.2016.08.012. Epub 2016 Sep 16.

35.

Chronic Disease Disparities by County Economic Status and Metropolitan Classification, Behavioral Risk Factor Surveillance System, 2013.

Shaw KM, Theis KA, Self-Brown S, Roblin DW, Barker L.

Prev Chronic Dis. 2016 Sep 1;13:E119. doi: 10.5888/pcd13.160088.

36.

Effects of a DXA result letter on satisfaction, quality of life, and osteoporosis knowledge: a randomized controlled trial.

Edmonds SW, Cram P, Lou Y, Jones MP, Roblin DW, Saag KG, Wright NC, Wolinsky FD; PAADRN Investigators.

BMC Musculoskelet Disord. 2016 Aug 26;17(1):369. doi: 10.1186/s12891-016-1227-0.

37.

The Impact of Using Mid-level Providers in Face-to-Face Primary Care on Health Care Utilization.

Liu H, Robbins M, Mehrotra A, Auerbach D, Robinson BE, Cromwell LF, Roblin DW.

Med Care. 2017 Jan;55(1):12-18.

PMID:
27367866
38.

Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.

Cram P, Wolinsky FD, Lou Y, Edmonds SW, Hall SF, Roblin DW, Wright NC, Jones MP, Saag KG; PAADRN Investigators.

Osteoporos Int. 2016 Dec;27(12):3513-3524. Epub 2016 Jun 30.

39.

Index of cardiometabolic health: a new method of measuring allostatic load using electronic health records.

Nobel L, Roblin DW, Becker ER, Druss BG, Joski PI, Allison JJ.

Biomarkers. 2017 Jul;22(5):394-402. doi: 10.1080/1354750X.2016.1201535. Epub 2016 Jun 30.

40.

A novel method for estimating transgender status using electronic medical records.

Roblin D, Barzilay J, Tolsma D, Robinson B, Schild L, Cromwell L, Braun H, Nash R, Gerth J, Hunkeler E, Quinn VP, Tangpricha V, Goodman M.

Ann Epidemiol. 2016 Mar;26(3):198-203. doi: 10.1016/j.annepidem.2016.01.004. Epub 2016 Feb 4.

41.

Primary care physicians' willingness to disclose oncology errors involving multiple providers to patients.

Mazor K, Roblin DW, Greene SM, Fouayzi H, Gallagher TH.

BMJ Qual Saf. 2016 Oct;25(10):787-95. doi: 10.1136/bmjqs-2015-004353. Epub 2015 Nov 3.

PMID:
26534996
42.

Psychosocial stress and changes in estimated glomerular filtration rate among adults with diabetes mellitus.

Annor FB, Masyn KE, Okosun IS, Roblin DW, Goodman M.

Kidney Res Clin Pract. 2015 Sep;34(3):146-53. doi: 10.1016/j.krcp.2015.07.002. Epub 2015 Aug 19.

43.

Health literacy-listening skill and patient questions following cancer prevention and screening discussions.

Mazor KM, Rubin DL, Roblin DW, Williams AE, Han PK, Gaglio B, Cutrona SL, Costanza ME, Wagner JL.

Health Expect. 2016 Aug;19(4):920-34. doi: 10.1111/hex.12387. Epub 2015 Jul 22.

44.

The personal shopper--a pilot randomized trial of grocery store-based dietary advice.

Lewis KH, Roblin DW, Leo M, Block JP.

Clin Obes. 2015 Jun;5(3):154-61. doi: 10.1111/cob.12095. Epub 2015 Apr 15.

45.

E-mail to Promote Colorectal Cancer Screening Within Social Networks: Acceptability and Content.

Cutrona SL, Wagner J, Roblin DW, Gaglio B, Williams A, Torres-Stone R, Mazor KM.

J Health Commun. 2015;20(5):589-98. doi: 10.1080/10810730.2015.1012238. Epub 2015 Apr 3.

46.

Work-related psychosocial stress and glycemic control among working adults with diabetes mellitus.

Annor FB, Roblin DW, Okosun IS, Goodman M.

Diabetes Metab Syndr. 2015 Apr-Jun;9(2):85-90. doi: 10.1016/j.dsx.2015.02.003. Epub 2015 Mar 6.

PMID:
25818923
47.

Improving bone mineral density reporting to patients with an illustration of personal fracture risk.

Edmonds SW, Cram P, Lu X, Roblin DW, Wright NC, Saag KG, Solimeo SL; PAADRN Investigators.

BMC Med Inform Decis Mak. 2014 Nov 25;14:101. doi: 10.1186/s12911-014-0101-y.

48.

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.

Roblin D, Yosipovitch G, Boyce B, Robinson J, Sandy J, Mainero V, Wickramasinghe R, Anand U, Anand P.

Acta Derm Venereol. 2015 May;95(5):542-8. doi: 10.2340/00015555-2047.

49.

Oxidative balance score and oxidative stress biomarkers in a study of Whites, African Americans, and African immigrants.

Lakkur S, Bostick RM, Roblin D, Ndirangu M, Okosun I, Annor F, Judd S, Dana Flanders W, Stevens VL, Goodman M.

Biomarkers. 2014 Sep;19(6):471-80. doi: 10.3109/1354750X.2014.937361. Epub 2014 Jul 2.

50.

Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG.

Med Care. 2014 Aug;52(8):743-50. doi: 10.1097/MLR.0000000000000170.

Supplemental Content

Loading ...
Support Center